SEC Form 4 · accession 0001104659-17-060659
OCULAR THERAPEUTIX, INC · OCUL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald Notman
Officer — Chief Financial Officer
Period of report
Oct 2, 2017
Accepted (ET)
Oct 3, 2017 · 5:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001393434
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $6.30 | Oct 2, 2017 | A | 125,000 | A | — | Oct 1, 2027 | Common Stock | 125,000 | 125,000 | D |
Explanation of responses
- F1Vests over four years, with 25% of the shares underlying the option vesting on the one-year anniversary of the reporting person's first date of employment and 2.0833% of the shares vesting monthly thereafter.